Kevin Schmidt Tanager

Assistant Professor of Pathology

kevin.tanager@duke.edu

More About This Person

At a Glance

Credentials
1. Education

Academic Experience
1. Current Duke Appointments & Affiliations

Global Scholarship

Keywords

Research

Scholarly Works
1. Featured Works
2. Conferences

Teaching & Mentoring

Recognition

Professional Activities

Embed Profile Data

Embed Profile Data

Scholarly Works

Abstract CT184: Preliminary results of first-line botensilimab (BOT) and balstilimab (BAL) optimization in microsatellite stable colorectal cancer (MSS CRC) without liver, bone, or brain metastasis (BBOpCo)

Conference Cancer Research · April 17, 2026 AbstractPatients (pts) with metastatic (met) MSS CRC are treated with sequential lines of chemotherapy (chemo), but most experience progression and prolonged toxicities during their disease course. BOT is ... Full text Cite

674 Association Between Histopathologic Features and Serum Circulating Tumor DNA Detection in Colorectal Cancer

Conference Laboratory Investigation · March 2026 Full text Cite